US Stock MarketDetailed Quotes

Sellas Life Sciences (SLS)

Watchlist
  • 5.220
  • +0.290+5.88%
Close Apr 17 16:00 ET
  • 5.450
  • +0.230+4.41%
Post 20:01 ET
937.42MMarket Cap-20.88P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sellas Life Sciences (SLS) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-10.28%28.27M
19.33%8.26M
-3.36%7.08M
-9.81%6.87M
-37.14%6.06M
-16.78%31.51M
-15.40%6.92M
-21.71%7.33M
-15.79%7.62M
-14.50%9.65M
Selling and administrative expenses
-1.33%12.25M
42.08%3.53M
-3.37%2.87M
23.29%3M
-36.97%2.86M
-10.42%12.42M
-19.45%2.48M
-16.38%2.97M
-22.13%2.44M
10.40%4.53M
-General and administrative expense
-1.33%12.25M
42.08%3.53M
-3.37%2.87M
23.29%3M
-36.97%2.86M
-10.42%12.42M
-19.45%2.48M
-16.38%2.97M
-22.13%2.44M
10.40%4.53M
Research and development costs
-16.10%16.02M
6.60%4.73M
-3.35%4.22M
-25.36%3.87M
-37.29%3.21M
-20.46%19.1M
-12.95%4.44M
-24.96%4.36M
-12.44%5.19M
-28.76%5.11M
Operating profit
10.28%-28.27M
-19.33%-8.26M
3.36%-7.08M
9.81%-6.87M
37.14%-6.06M
16.78%-31.51M
15.40%-6.92M
21.71%-7.33M
15.79%-7.62M
14.50%-9.65M
Net non-operating interest income expense
123.26%1.41M
229.83%597K
32.13%292K
80.13%272K
216.46%250K
20.38%632K
341.46%181K
135.11%221K
-27.40%151K
-56.59%79K
Non-operating interest income
123.26%1.41M
229.83%597K
32.13%292K
80.13%272K
216.46%250K
20.38%632K
341.46%181K
135.11%221K
-27.40%151K
-56.59%79K
Other net income (expense)
Income before tax
13.01%-26.86M
-13.67%-7.66M
4.46%-6.79M
11.63%-6.6M
39.23%-5.81M
17.30%-30.88M
17.20%-6.74M
23.30%-7.11M
15.50%-7.47M
13.80%-9.57M
Income tax
Net income
13.01%-26.86M
-13.67%-7.66M
4.46%-6.79M
11.63%-6.6M
39.23%-5.81M
17.30%-30.88M
17.20%-6.74M
23.30%-7.11M
15.50%-7.47M
13.80%-9.57M
Net income continuous Operations
13.01%-26.86M
-13.67%-7.66M
4.46%-6.79M
11.63%-6.6M
39.23%-5.81M
17.30%-30.88M
17.20%-6.74M
23.30%-7.11M
15.50%-7.47M
13.80%-9.57M
Minority interest income
Net income attributable to the parent company
13.01%-26.86M
-13.67%-7.66M
4.46%-6.79M
11.63%-6.6M
39.23%-5.81M
17.30%-30.88M
17.20%-6.74M
23.30%-7.11M
15.50%-7.47M
13.80%-9.57M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
13.01%-26.86M
-13.67%-7.66M
4.46%-6.79M
11.63%-6.6M
39.23%-5.81M
17.30%-30.88M
17.20%-6.74M
23.30%-7.11M
15.50%-7.47M
13.80%-9.57M
Basic earnings per share
50.00%-0.25
37.50%-0.05
40.00%-0.06
46.15%-0.07
66.67%-0.07
62.69%-0.5
68.00%-0.08
69.70%-0.1
58.06%-0.13
55.32%-0.21
Diluted earnings per share
50.00%-0.25
37.50%-0.05
40.00%-0.06
46.15%-0.07
66.67%-0.07
62.69%-0.5
68.00%-0.08
69.70%-0.1
58.06%-0.13
55.32%-0.21
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -10.28%28.27M19.33%8.26M-3.36%7.08M-9.81%6.87M-37.14%6.06M-16.78%31.51M-15.40%6.92M-21.71%7.33M-15.79%7.62M-14.50%9.65M
Selling and administrative expenses -1.33%12.25M42.08%3.53M-3.37%2.87M23.29%3M-36.97%2.86M-10.42%12.42M-19.45%2.48M-16.38%2.97M-22.13%2.44M10.40%4.53M
-General and administrative expense -1.33%12.25M42.08%3.53M-3.37%2.87M23.29%3M-36.97%2.86M-10.42%12.42M-19.45%2.48M-16.38%2.97M-22.13%2.44M10.40%4.53M
Research and development costs -16.10%16.02M6.60%4.73M-3.35%4.22M-25.36%3.87M-37.29%3.21M-20.46%19.1M-12.95%4.44M-24.96%4.36M-12.44%5.19M-28.76%5.11M
Operating profit 10.28%-28.27M-19.33%-8.26M3.36%-7.08M9.81%-6.87M37.14%-6.06M16.78%-31.51M15.40%-6.92M21.71%-7.33M15.79%-7.62M14.50%-9.65M
Net non-operating interest income expense 123.26%1.41M229.83%597K32.13%292K80.13%272K216.46%250K20.38%632K341.46%181K135.11%221K-27.40%151K-56.59%79K
Non-operating interest income 123.26%1.41M229.83%597K32.13%292K80.13%272K216.46%250K20.38%632K341.46%181K135.11%221K-27.40%151K-56.59%79K
Other net income (expense)
Income before tax 13.01%-26.86M-13.67%-7.66M4.46%-6.79M11.63%-6.6M39.23%-5.81M17.30%-30.88M17.20%-6.74M23.30%-7.11M15.50%-7.47M13.80%-9.57M
Income tax
Net income 13.01%-26.86M-13.67%-7.66M4.46%-6.79M11.63%-6.6M39.23%-5.81M17.30%-30.88M17.20%-6.74M23.30%-7.11M15.50%-7.47M13.80%-9.57M
Net income continuous Operations 13.01%-26.86M-13.67%-7.66M4.46%-6.79M11.63%-6.6M39.23%-5.81M17.30%-30.88M17.20%-6.74M23.30%-7.11M15.50%-7.47M13.80%-9.57M
Minority interest income
Net income attributable to the parent company 13.01%-26.86M-13.67%-7.66M4.46%-6.79M11.63%-6.6M39.23%-5.81M17.30%-30.88M17.20%-6.74M23.30%-7.11M15.50%-7.47M13.80%-9.57M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 13.01%-26.86M-13.67%-7.66M4.46%-6.79M11.63%-6.6M39.23%-5.81M17.30%-30.88M17.20%-6.74M23.30%-7.11M15.50%-7.47M13.80%-9.57M
Basic earnings per share 50.00%-0.2537.50%-0.0540.00%-0.0646.15%-0.0766.67%-0.0762.69%-0.568.00%-0.0869.70%-0.158.06%-0.1355.32%-0.21
Diluted earnings per share 50.00%-0.2537.50%-0.0540.00%-0.0646.15%-0.0766.67%-0.0762.69%-0.568.00%-0.0869.70%-0.158.06%-0.1355.32%-0.21
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -